Mark Doucet has joined Valens GroWorks Corp. (CSE:VGW) as its president.
Mark Doucet has more than 25 years of senior executive experience. He has been involved in and advised on capital markets, infrastructure, commercial real estate, precious metals and other industries both foreign and domestic. Past service includes: President of a US junior exploration company, President of a business/government relations company, Founder and President of a wireless application company, and Vice President for several Canadian junior exploration companies, an international government/business consulting firm and an Atlantic Canada restaurant franchise. Mark served as Financial Officer and Development Planner for the privatization and redevelopment of Toronto’s Pearson International Airport. Mark and his wife have two boys, and reside in Ottawa.
Mark commented “Valens GroWorks Corp. has vastly superior products and people completely motivated to realize their vision of excellence by leading this quickly evolving industry. Drawing on this vision, I am passionately energized to help the Valens GroWorks team become an industry leader in this space.”
Robert van Santen, the Company’s CEO and Chair commented “I am particularly pleased that a seasoned and visionary leader like Mark has chosen our Company and its team as his vehicle to enter into this rapid-growth sector as the repeal of prohibition looms in Canada. The industry is in transition from the legacy world of commercial marijuana — legal, quasi-legal, gray market, illicit — to the future, which will see a fully institutionalized market.”
Read the full company profile.
The Company is granting stock options to acquire an aggregate of one million common shares in the capital of the Company at an exercise price of $1.40 per common share, expiring on the fifth anniversary of the grant (collectively, the “Stock Option”). The Stock Option vests in stages over the course of two (2) years with 12.5% to vest immediately and a further 12.5% to vest in each three-month period thereafter, and is exercisable quarterly after 12 months, with the balance after 24 months from the Commencement Date. The Stock Options are being granted in accordance with the Company’s stock option plan, and are subject to regulatory approval.
About Valens GroWorks Corp.
Valens GroWorks Corp is a Canadian Securities Exchange listed company with an aggressive acquisition strategy in progress, providing management, consulting, testing and support services to domestic and international licensees, as well as financing the buildout of established, fully-licensed operations pursuant to its investment in Arizona. The Company seeks to capture a broad spectrum of medical marijuana users, as well as recreational users once legalized, in pursuit of its ambitious seed to sale and farm to pharma objectives.
The Company’s wholly-owned subsidiary, Valens Agritech Ltd. (“VAL”), is a post-inspection applicant awaiting the granting of a Controlled Drugs and Substances Dealer’s Licence for the cultivation and processing of marijuana. Based in the Okanagan Valley of British Columbia, VAL anticipates participation in selective clinical trial programs researching the efficacy of medical cannabis.
The Company is about to close the signed Share Exchange Agreement (SEA) with Supra THC Services Inc. (“Supra”) which will become a wholly-owned subsidiary. Supra holds a Health Canada Dealer’s Licence and is providing sector-leading analytical services for Licensed Producers and ACMPR patients.
Connect with Valens GroWorks Corp. (CSE:VGW) to receive an Investor Presentation.
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.
For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/
INVESTOR ALERT: ROSEN, AN INVESTOR RIGHTS LAW FIRM, Encourages Aurora Cannabis Inc. Investors to Seek Counsel Before Important December 1 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ACB
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE:ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws
TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced Jason Ackerman Chief Executive Officer and Executive Chairman of TerrAscend, Keith Stauffer Chief Financial Officer, and Jason Wild Chairman, will participate in three upcoming conferences:
- Cowen’s 3rd Annual Boston Cannabis Conference, a virtual event taking place November 30-December 2 , 2020. Jason Ackerman will participate in a panel, U.S. MSOs: The West, on November 30, 2020 at 10:25 a.m. ET . Management will also host one-on-one meetings with investors throughout the conference.
- 2020 Cantor Fitzgerald Virtual Cannabis MSO Summit, a virtual event taking place on December 15-16, 2020 . Jason Ackerman is scheduled to participate in a fireside chat on December 16 th at 1:00 p.m. ET . To register for the fireside chat: Click Here
- 23 rd Annual Needham Virtual Growth Conference, a virtual event taking place January 11-15, 2021 . Jason Ackerman is scheduled to participate in a fireside chat on January 14, 2021 at 2:45 p.m. ET . Management will also host one-on-one meetings with investors throughout the conference. To register for the fireside chat: Click Here
The Canadian Securities Exchange (“CSE”) has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
- Aurora strategically positioned within two of the largest legal cannabis markets outside of Canada
- Agreement with Israeli leader Cantek provides access to Israel’s drugstore channel
- Finished product is co-branded under Aurora and Cantek brands
NYSE | TSX: ACB
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today it has entered into a strategic Supply Agreement (the “Agreement”) with Cantek Holdings (“Cantek”), one of Israel’s leaders in the medical cannabis field.